Two Medtronic plc innovations were acknowledged in updated guidelines published by the European Society of Cardiology (ESC): cryoballoon ablation for patients with diagnosed atrial fibrillation (AF), and long-term cardiac monitoring
for survivors of stroke who do not have an established diagnosis of AF.
The Corsens Cardiac Monitor is intended to participate in the global cardiac monitoring
and cardiac rhythm management devices market which is expected to reach USD 12.
However, continuous monitoring solutions are in development for the large and growing market for ambulatory cardiac monitoring
devices, valued at $1.
10 September 2014 - US remote patient monitoring systems provider Preventice Inc has combined with domestic remote cardiac monitoring
products and services firm eCardio Diagnostics LLC, the parties announced.
BULLETIN BOARD: BTEL) and a world leader in ambulatory cardiac monitoring
devices, has introduced the ER920W, an advanced wireless device that integrates cardiac arrhythmia monitoring and cell phone technologies in one unit.
CLINTON - The Clinton Hospital has invested about $300,000 to upgrade cardiac monitoring
The retrospective capabilities of full disclosure aid clinicians in careful yet efficacious cardiac monitoring
The cardiac monitoring
and cardiac rhythm management devices market is divided into two segments, namely,conventional monitoring devices and cardiac rhythm management (CRM) devices; the market is forecast till 2017.
The MoMe Kardia system supports the use of three cardiac monitoring
modes Holter monitoring, event monitoring, and mobile cardiovascular telemetry (MCT).
8 May 2013 - The global market for cardiac monitoring
and diagnostic devices has been forecast to grow by 11% annually to USD 12.
Unfortunately, current ambulatory cardiac monitoring
(Holter, event and MCT) relies on complex devices with antiquated technology or inefficient and ineffective monitoring systems to capture and analyze patient data.
today announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial Fibrillation) Clinical Trial, which found that continuous cardiac monitoring
with the Reveal XT Insertable Cardiac Monitor (ICM) was superior to standard care at detecting atrial fibrillation (AF) in patients who have had strokes of undetermined causes (cryptogenic stroke).